Several of these were of particular relevance to cellular pathways implicated in AD, including significant upregulations in vesicle-associated protein VAMP2 (fold change 1.5, p = 0.036), the Aβ binding protein SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha; fold change 1.9, p = 0.018) and the AD-associated, CNS development and maturation protein DPYL5 (Dihydropyrimidinase-related protein 5, AKA CRMP5, fold change 1.4, p = 0.047). The gene discussed is SGTA; the disease is Alzheimer disease.